Biogen (BIIB) volatility Elevated collapses as shares rally on EPS
Tweet Send to a Friend
Biogen (Nasdaq: BIIB) is recently up $4.10 to $70.95. BIIB reported Q2 EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
